[18F]AlF-NOTA-A6P

N/A

Report date: 2025/11/18 13:23:00
NME

Base Information

Drug Name[18F]AlF-NOTA-A6P
Drug Alias Name[18F]AlF-NOTA-A6P
ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC) +[4] 
Mechanisms of ActionIntegrin Subunit Alpha 6 binders
TargetsIntegrin Subunit Alpha 6
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWuxi Nuoyu Pharmaceutical Technology Co LtdAffiliated Hospital of Jiangnan University
China Registration ClassN/A

Develop Information

Active CompaniesWuxi Nuoyu Pharmaceutical Technology Co LtdAffiliated Hospital of Jiangnan University
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A